Morning Symposium - Nurses’ Professional Group - Fertility Preservation: Time is of the Essence
Date:October 22,
2012
Time:11:15 am - 1:00 pm
Location:Room 4 - San Diego Convention Center
Presenters
Andrea J. Speck-Zulak, N.P., R.N. (Chair), Oregon Reproductive Medicine
Deborah Mecerod, R.N., Reproductive Biology Associates
Lynn Westphal, M.D., Stanford University
Fertility Preservation: Time is of the Essence
Needs Assessment and Description
Recent advances in egg freezing (oocyte cryopreservation)
have opened the options for women wishing to preserve
fertility until the time at which they are ready to begin
their family. Egg freezing offers women the potential to
“preserve” their fertility without feeling the pressures of the
biological clock. In addition, freezing oocytes for cancer
patients and egg donors, and as an adjunct to assisted
reproductive technology (ART) procedures, may completely
change our ability to assist these patients. This live course for
nurses and other healthcare professionals will cover current
information on oocyte cryopreservation and its use in ART.
Learning Objectives
At the conclusion of this session, participants should be able
to:
- Review the history and physiology of human egg freezing
and thawing (including egg vitrification and “warming”).
- Discuss egg freezing potential for women utilizing
the technology for social reasons, for patients recently
diagnosed with cancer, for donors and as a back-up
option during ART procedures.
ACGME Competency
Patient Care
TEST QUESTION:
A 38-year-old woman is diagnosed with breast cancer. She
is interested in her options and chances of pregnancy in the
future. After participating in this session, in my practice I will
counsel this woman that:
- All types of chemotherapy have a similar risk of ovarian
failure.
- Ovarian stimulation concurrent with letrozole is not
associated with increased breast cancer recurrence in
5-year follow up.
- Pregnancy after breast cancer increases recurrence
rates.
- Regular menstruation after chemotherapy signifies
normal fertility.
- Chemotherapy increases her risk of birth defects if she
tries to conceive a year after completing treatment.
- Not applicable to my area of practice.